The release of proinflammatory factors from tumor or stromal cells—in the form of soluble factors or those contained in exosomes—into the bloodstream alters the production of APPs, metabolites, and cells, which impacts organs and systems, causing the appearance of symptoms unrelated to the tumor itself, called paraneoplastic syndromes (6). Here, CTSB is linked to neoplasm.